Free Trial

Ascendis Pharma A/S (ASND) Earnings Date, Estimates & Call Transcripts

Ascendis Pharma A/S logo
$132.68 -0.83 (-0.62%)
(As of 11:30 AM ET)

Ascendis Pharma A/S Latest Earnings Summary

Latest Q2 2024
Earnings Date
Sep. 3Confirmed
Actual EPS
(Sep. 3)
-$2.05 Missed By -$0.51
Consensus EPS
(Sep. 3)
-$1.54

Ascendis Pharma A/S announced Q2 2024 earnings on September 3, 2024, reporting an EPS of -$2.05, which missed analysts' consensus estimates of -$1.54 by $0.51. Quarterly revenue was reported to be $38.75 million, below the consensus estimate of $94.74 million. With a trailing EPS of -$8.08, Ascendis Pharma A/S's earnings are expected to grow next year, from ($7.45) to ($4.30) per share.

Get Ascendis Pharma A/S Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ascendis Pharma A/S and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ASND Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ASND Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ascendis Pharma A/S Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$2.16-$2.16-$2.16
Q2 20242-$1.98-$1.07-$1.53
Q3 20242-$1.98-$1.96-$1.97
Q4 20242-$1.72-$1.71-$1.72
FY 20247-$7.84-$6.90-$7.37
Q1 20252-$1.86-$1.56-$1.71
Q2 20252-$1.37-$1.25-$1.31
Q3 20252-$1.11-$1.01-$1.06
Q4 20252-$0.77$1.25$0.24
FY 20258($5.11)($2.57)($3.84)

Ascendis Pharma A/S Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
9/3/2024Q2 2024-$1.54-$2.05 -$0.51-$2.05$94.74M$38.75M
5/2/2024Q1 2024-$1.57-$2.48 -$0.91-$2.48$85.72M$103.11M
2/7/2024Q4 2023-$2.15-$1.66+$0.49-$1.66$97.02M$148.62M
11/7/2023Q3 2023-$2.63-$3.12 -$0.49-$3.12$52.54M$52.02M
9/5/2023Q2 2023-$2.68-$2.35+$0.33-$2.35$41.73M$51.59M
4/27/2023Q1 2023-$2.84-$2.12+$0.72-$2.12$24.53M$36.04M
2/16/2023Q4 2022-$2.50-$3.78 -$1.28-$3.78$20.31M$23.38M

Ascendis Pharma A/S Earnings - Frequently Asked Questions

Ascendis Pharma A/S (NASDAQ:ASND) last announced its quarterly earning data on Tuesday, September 3, 2024. Learn more on ASND's earnings history.

In the previous quarter, Ascendis Pharma A/S (NASDAQ:ASND) missed the analysts' consensus estimate of ($1.54) by $0.51 with a reported earnings per share (EPS) of ($2.05). Learn more on analysts' earnings estimate vs. ASND's actual earnings.

Ascendis Pharma A/S (NASDAQ:ASND) has a recorded annual revenue of $288.08 million.

Ascendis Pharma A/S (NASDAQ:ASND) has a recorded net income of -$521.07 million. ASND has generated -$8.08 earnings per share over the last four quarters.

Ascendis Pharma A/S's earnings are expected to grow from ($7.45) per share to ($4.30) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ASND) was last updated on 12/3/2024 by MarketBeat.com Staff
From Our Partners